• Treatment-as-prevention only viable with expanded HCV coverage

    19 days ago - By Healio

    Results of a modeling study showed that in dense urban settings with high prevalence of hepatitis C among people who inject drugs, HCV treatment-as-prevention strategies will have little impact over 10 years unless coverage is greatly expanded.
    “With the availability of more tolerable and eective direct-acting antivirals, HCV treatment-as-prevention strategies could substantially curtail HCV transmission and reduce the burden of HCV,” Alexei Zelenev, PhD, from the Yale School of Medicine in Connecticut, and colleagues wrote. “Completely eliminating HCV... will require a
    Read more ...